-
Your selected country is
Ireland
- Change country/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
BD Cytognos™ Act-T4 Cell antibody combination
(RUO)
Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Description
Act-T4 Cell™ kit allows developing a functional assay for measuring of immune response mediated by activated CD4+ T cells. This kit is based on a patented method (OX40 assay) for the identification of a subpopulation of CD4 effector T cells; these cells present the activation markers CD134 and CD25 on their surface, which can be detected and quantified by flow cytometry after incubating blood with mitogens and/or specific antigens of pathogens to study. The increase in the percentage of this subpopulation of activated CD4+ T cells is indicative of immune responsiveness of the organism to the applied stimulus.
Description | Quantity/Size | Part Number | EntrezGene ID |
---|---|---|---|
Act-T4 Cell antibody combination | 100 Tests (1 ea) | CYT-AT4C-ABMIX | N/A |
Act-T4 Cell lysing solution | 100 Tests (1 ea) | CYT-AT4C-L | N/A |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.